[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 24 2008

Lowering Homocysteine With B Vitamins in Patients With Coronary Artery Disease

JAMA. 2008;300(24):2852-2854. doi:10.1001/jama.2008.837

To the Editor: The WENBIT study by Dr Ebbing and colleagues1 appears to refute the hypothesis of homocysteine as a cardiovascular risk factor. However, some important aspects were not considered in the article's discussion.

Homocysteine is a long-term risk factor. In the Gothenburg study,2 women with a high homocysteine level showed a higher mortality only after a follow-up of more than 15 years. Thus, short-term follow-up after cardiovascular events will probably not be able to demonstrate a benefit of B vitamins.

First Page Preview View Large
First page PDF preview
First page PDF preview
×